CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (140,775)	$ (59,801)
Adjustments to reconcile net loss to cash used in operating activities:
Impairment of long-lived assets	3,297	1,488
Amortization and depreciation	3,951	2,858
Amortization of right-of-use asset	908	733
Amortization of inventory step-up		978
Unrealized loss on investment		5
GVB fire write-offs		4,549
Other non-cash (gains) and losses	(15)	563
Provision for credit losses	1,024	770
(Gain) loss on the sale of machinery and equipment	73	(368)
Realized loss (gain) on Panacea investment		2,789
Inventory write-off		237
Debt related charges included in interest expense	8,006
Equity-based employee compensation expense	2,679	5,489
Gain on change of contingent consideration	(1,138)
Change in fair value of warrant liabilities	(364)
Change in fair value of derivative liability	557
Loss on disposal of discontinued operations	58,521
Loss on transfer of promissory note	895
Deferred income taxes	434	(434)
Increase in inventory reserves	8,695
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	(18)	(2,881)
Inventory	(5,925)	(8,789)
Prepaid expenses and other assets	451	(920)
Accounts payable	4,752	416
Accrued expenses	681	(582)
Accrued payroll	(2,153)	748
Accrued excise taxes and fees	811	153
Other liabilities	(334)	285
Net cash used in operating activities	(54,987)	(51,714)
Cash flows from investing activities:
Acquisition of patents, trademarks, and licenses	(961)	(772)
Acquisition of property, plant and equipment	(4,656)	(3,657)
Proceeds from the sale of property, plant and equipment	283	409
Acquisition, net of cash acquired	(254)	(1,297)
Proceeds from sale of discontinued operations	665
Investment in Change Agronomy Ltd.		(682)
Property, plant and equipment insurance proceeds	3,500
Sales and maturities of short-term investment securities	21,714	101,990
Purchase of short-term investment securities	(3,475)	(73,413)
Net cash provided by investing activities	16,816	22,578
Cash flows from financing activities:
Payments on notes payable	(5,581)	(3,822)
Proceeds from issuance of notes payable	2,360	2,162
Other financing activities		(29)
Payments of long-term debt	(9,700)
Proceeds from issuance of long-term debt	16,849
Payment of debt issuance costs	(801)
Proceeds from issuance of detachable warrants	6,016
Net proceeds from option exercise		174
Net proceeds from warrant exercise	3,044
Taxes paid related to net share settlement of RSUs	(420)	(149)
Net cash provided by financing activities	37,209	30,820
Net (decrease) increase in cash and cash equivalents	(962)	1,684
Cash and cash equivalents - beginning of period	3,020	1,336
Cash and cash equivalents - end of period	2,058	3,020
Net cash paid for:
Cash paid during the period for interest	1,313	34
Cash paid during the period for income taxes	40	14
Non-cash transactions:
Capital expenditures incurred but not yet paid	118	$ 94
Right-of-use assets and corresponding operating lease obligations	5,166
Non-cash assignment of PLSH Promissory Note	2,600
Insurance/litigation gross up	3,768
Non-cash proceeds from sale of discontinued operations	2,000
Deemed dividends	9,801
Stock issued in connection with acquisition		51,653
Non-cash consideration RXP acquisition	1,641
Non-cash licensing arrangement	3,500
ATM
Cash flows from financing activities:
Proceeds from issuance of common stock	2,741
Payment of common stock issuance costs	(178)
Registered Direct Offering
Cash flows from financing activities:
Proceeds from issuance of common stock	25,158	$ 35,000
Payment of common stock issuance costs	$ (2,279)	$ (2,516)